Robert Negrin
Corporate Officer/Principal at Stanford University
Profile
Robert Negrin is the founder of Magenta Therapeutics, Inc. (founded in 2015).
He is currently a Professor at Stanford University and a Member of the Association of American Physicians.
Dr. Negrin was formerly the President of the American Society for Blood & Marrow Transplantation.
He received his doctorate from Harvard University and his undergraduate degree from the University of California, Berkeley.
Dr. Negrin is also the founder of BioEclipse Therapeutics, Inc.
Robert Negrin active positions
| Companies | Position | Start |
|---|---|---|
| Stanford University | Corporate Officer/Principal | - |
Association of American Physicians
 Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Corporate Officer/Principal | - |
Former positions of Robert Negrin
| Companies | Position | End |
|---|---|---|
| American Society for Blood & Marrow Transplantation | President | - |
BioEclipse Therapeutics, Inc.
 BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Founder | - |
| MAGENTA THERAPEUTICS | Founder | - |
Training of Robert Negrin
| University of California, Berkeley | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Commercial Services |
| American Society for Blood & Marrow Transplantation | |
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Robert Negrin
